Thanks Chelseadude65.
I'm aware that first patient dosage was specified as before Q1 of 2024 - meaning end of March. I'm more interested in when could we expect the results of the phase 2 trial. For clarity, efficacy data.
I don't remember this ever being stated when I was reading through the company presentations and announcements .
General Discussions, page-64
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
85.0¢ |
Change
-0.025(2.86%) |
Mkt cap ! $105.1M | |||
| Open | High | Low | Value | Volume |
| 84.8¢ | 85.5¢ | 81.5¢ | $210.7K | 253.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5440 | 83.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 86.0¢ | 9235 | 2 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| AGN (ASX) Chart |